Second-quarter net income rose to $561 million, boosted by $129 million in tariff refunds and strong diagnostic device sales.
GE HealthCare reported second-quarter net income of $561 million, up from $486 million a year earlier. The increase was driven by strong demand for diagnostic and imaging devices, along with $129 million in tariff refunds from duties imposed during the Trump administration.
The company’s adjusted core margin declined 40 basis points year-over-year due to higher costs for memory chips, oil, and freight. Despite geopolitical instability affecting supply chains, GE HealthCare maintained its annual profit forecast earlier this month.
Shares rose 12% in premarket trading as investors monitored sector trends after HCA Healthcare warned of softer demand for surgical procedures and rising uninsured patient rates.